-
Egg Prices Jump Before Holidays as Bird Flu Spreads
Costs have soared again amid a bird flu outbreak, bringing renewed attention to the fact that while inflation is cooling, prices are still elevated.
-
For Syria’s Economy, the Way Forward Starts With Sanctions Relief
Years of strife ruined the energy sector, battered the currency and strangled growth. The West must ease financial controls to help the economy, experts say.
-
For Syria’s Economy, the Way Forward Starts With Sanctions Relief
Years of strife ruined the energy sector, battered the currency and strangled growth. The West must ease financial controls to help the economy, experts say.
-
From Inflation to Bitcoin, 9 Charts That Explain 2024
Rate cuts, stock surges, and Trump’s tariff threats are among the biggest forces shaping business and the economy.
-
From Inflation to Bitcoin, 9 Charts That Explain 2024
Rate cuts, stock surges, and Trump’s tariff threats are among the biggest forces shaping business and the economy.
-
How to Keep ‘People Pleasing” From Ruining Your Finances
Spending money to avoid conflict or gain social acceptance can ruin your finances. Some self-reflection and support from professionals can help turn things around.
-
Google Proposes Fix to Solve Search Monopoly
The search giant’s proposals included allowing flexibility for companies and consumers in choosing a search engine.
-
G.O.P. Spending Hawks Defy Trump on the Debt Limit, Previewing More Clashes
President-elect Donald J. Trump is known for his tight grip on members of his party, but the rare rejection of his demand to suspend the debt limit reflected a disconnect that could plague his policy agenda.
-
Congress Approves Spending Extension, Ending Shutdown Crisis
The Senate passed the measure, sending it to President Biden’s desk, shortly after the midnight deadline for funding to lapse.
-
New Accelerated Approval Guidance Underscores Need for Accountability
On December 5, 2024, just in time for the holidays, the U.S. Food and Drug Administration (“FDA” or the “Agency”) released a draft guidance titled “Expedited Program for Serious Conditions: Accelerated Approval of Drugs and Biologics Guidance for Industry” (the “Draft Guidance”)……By: Sheppard Mullin Richter & Hampton LLP
